Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06529003 · ClinicalTrials.gov registry record · NA
TENS Unit To Decrease Pain After Laminaria Insertion
A NA study, sponsored by Queen's Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT06529003 is a NA study that has completed, run by Queen's Medical Center. The registered enrollment target is 36 participants.
The verdict
NCT06529003, a NA study, has completed, sponsored by Queen's Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of the study is to learn more about the transcutaneous nerve stimulation (TENS) unit, an over-the-counter option for pain relief that is not a medication. The investigators are hoping to find out if this device decreases pain during and after laminaria placement for patients undergoing both elective and medically indicated second-trimester termination of pregnancy.
Interventions
- DEVICE Placebo
- DEVICE Transcutaneous Electrical Nerve Stimulation (TENS) unit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2024-08-14 |
| Est. Completion | 2025-11-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06529003
The ClinicalTrials.gov registry entry for NCT06529003 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Queen's Medical Center, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06529003 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06529003 about?
NCT06529003 is a clinical study titled "TENS Unit To Decrease Pain After Laminaria Insertion". The purpose of the study is to learn more about the transcutaneous nerve stimulation (TENS) unit, an over-the-counter option for pain relief that is not a medication. The investigators are hoping to find out if this device decreases pain during and after laminaria placement for patients undergoing b...
What is the current status of trial NCT06529003?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2024-08-14. Estimated completion is 2025-11-05.
What interventions are being tested in trial NCT06529003?
The interventions under investigation include: Placebo (DEVICE), Transcutaneous Electrical Nerve Stimulation (TENS) unit (DEVICE).
Who is sponsoring clinical trial NCT06529003?
This trial is sponsored by Queen's Medical Center, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.